What is Dermata Therapeutics Inc's share price today?
Dermata Therapeutics Inc (DRMA) share price today is $0.84 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $0.87 and a day low of $0.81.What exchange does Dermata Therapeutics Inc stock trade on, and under what ticker symbol?
Dermata Therapeutics Inc stock trades on NASDAQ under the ticker symbol DRMA.What is Dermata Therapeutics Inc's market capitalization?
Dermata Therapeutics Inc's market capitalization is $4.09M as of November 5, 2026 at 2:29 AM IST.What is Dermata Therapeutics Inc's price-to-earnings (P/E) ratio?
Dermata Therapeutics Inc's price-to-earnings (P/E) ratio is 0.08 as of November 4, 2026.What is Dermata Therapeutics Inc's price-to-book (P/B) ratio?
Dermata Therapeutics Inc's price-to-book (P/B) ratio is 0.59 as of November 4, 2026.Can Indian investors buy Dermata Therapeutics Inc shares?
Yes, You can buy Dermata Therapeutics Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Dermata Therapeutics Inc shares from India?
Indian investors can buy Dermata Therapeutics Inc shares in three steps: 1. Search Dermata Therapeutics Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Dermata Therapeutics Inc shares for Indian investors?
Since Dermata Therapeutics Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Dermata Therapeutics Inc shares via Tickertape?
Indian investors can start investing in Dermata Therapeutics Inc (DRMA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 11.8063 shares at the current price of $0.84.
$
₹
$0.84—% (+0.84)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
0.08
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0.59
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$15.24
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 1 analyst's reports
Buy1 analyst
Hold0 analyst
Sell0 analyst
Price Upside
+726.45%
Earnings Growth
—
Rev. Growth
—
Company Profile
Company Profile
ABBV
P/E Ratio
50.67
50.67
1Y Return
32.47%
32.47%
Buy Reco %
79.31
79.31
AMGN
P/E Ratio
28.90
28.90
1Y Return
56.57%
56.57%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
36.15%
36.15%
Buy Reco %
78.57
78.57
P/E Ratio
32.21
32.21
1Y Return
30.2%
30.2%
Buy Reco %
81.25
81.25
P/E Ratio
21.24
21.24
1Y Return
48.38%
48.38%
Buy Reco %
67.85
67.85
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Dermata Therapeutics Inc | 0.08 | 0.59 | - |
| AbbVie Inc | 50.67 | 50.45 | 0.60 |
| Amgen Inc | 28.90 | 21.55 | 2.77 |
Price Comparison
Price Comparison
Compare DRMA with any stock or ETFCompare DRMA with any stock or ETF
Comparing from
DRMA
ABBV
AMGN